These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9137980)

  • 1. Circulating tumor necrosis factor alpha is elevated in male but not in female patients with type II diabetes mellitus.
    Pfeiffer A; Janott J; Möhlig M; Ristow M; Rochlitz H; Busch K; Schatz H; Schifferdecker E
    Horm Metab Res; 1997 Mar; 29(3):111-4. PubMed ID: 9137980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated plasma levels of transforming growth factor-beta 1 in NIDDM.
    Pfeiffer A; Middelberg-Bisping K; Drewes C; Schatz H
    Diabetes Care; 1996 Oct; 19(10):1113-7. PubMed ID: 8886558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated plasma levels of soluble receptors of TNF-alpha and their association with smoking and microvascular complications in young adults with type 1 diabetes.
    Zoppini G; Faccini G; Muggeo M; Zenari L; Falezza G; Targher G
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3805-8. PubMed ID: 11502815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for the development of micro-vascular complications of type 2 diabetes in a single-centre cohort of patients.
    Teliti M; Cogni G; Sacchi L; Dagliati A; Marini S; Tibollo V; De Cata P; Bellazzi R; Chiovato L
    Diab Vasc Dis Res; 2018 Sep; 15(5):424-432. PubMed ID: 29911415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated levels of interleukin-18 and tumor necrosis factor-alpha in serum of patients with type 2 diabetes mellitus: relationship with diabetic nephropathy.
    Moriwaki Y; Yamamoto T; Shibutani Y; Aoki E; Tsutsumi Z; Takahashi S; Okamura H; Koga M; Fukuchi M; Hada T
    Metabolism; 2003 May; 52(5):605-8. PubMed ID: 12759891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relation between plasma endothelin-1 levels and metabolic control, risk factors, treatment modalities, and diabetic microangiopathy in patients with Type 2 diabetes mellitus.
    Ak G; Buyukberber S; Sevinc A; Turk HM; Ates M; Sari R; Savli H; Cigli A
    J Diabetes Complications; 2001; 15(3):150-7. PubMed ID: 11358684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum vaspin levels in type 2 diabetic women in relation to microvascular complications.
    Gulcelik NE; Karakaya J; Gedik A; Usman A; Gurlek A
    Eur J Endocrinol; 2009 Jan; 160(1):65-70. PubMed ID: 18952766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus.
    Navarro JF; Mora C; Maca M; Garca J
    Am J Kidney Dis; 2003 Jul; 42(1):53-61. PubMed ID: 12830456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased serum levels of interleukin-18 in patients with diabetic nephropathy.
    Mahmoud RA; el-Ezz SA; Hegazy AS
    Ital J Biochem; 2004 Jul; 53(2):73-81. PubMed ID: 15646011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High serum TNF-alpha level in Type 2 diabetic patients with microangiopathy is associated with eNOS down-regulation and apoptosis in endothelial cells.
    Makino N; Maeda T; Sugano M; Satoh S; Watanabe R; Abe N
    J Diabetes Complications; 2005; 19(6):347-55. PubMed ID: 16260352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Raised serum sialic acid concentration in NIDDM patients with and without diabetic nephropathy.
    Chen J; Gall MA; Yokoyama H; Jensen JS; Deckert M; Parving HH
    Diabetes Care; 1996 Feb; 19(2):130-4. PubMed ID: 8718432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Markers of the progression of complications in patients with type 2 diabetes: a one-year longitudinal study.
    Preciado-Puga MC; Malacara JM; Fajardo-Araujo ME; Wröbel K; Wröbel K; Kornhauser-Araujo C; Garay-Sevilla ME
    Exp Clin Endocrinol Diabetes; 2014 Sep; 122(8):484-90. PubMed ID: 25230243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macro-microangiopathy and endothelial dysfunction in NIDDM patients with and without diabetic nephropathy.
    Parving HH; Nielsen FS; Bang LE; Smidt UM; Svendsen TL; Chen JW; Gall MA; Rossing P
    Diabetologia; 1996 Dec; 39(12):1590-7. PubMed ID: 8960847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma angiotensin II, renin activity and serum angiotensin-converting enzyme activity in non-insulin dependent diabetes mellitus patients with diabetic nephropathy.
    Nicola W; Sidhom G; El Khyat Z; Ibrahim S; Salah A; El Sayed A
    Endocr J; 2001 Feb; 48(1):25-31. PubMed ID: 11403100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?
    Chico A; Pérez A; Córdoba A; Arcelús R; Carreras G; de Leiva A; González-Sastre F; Blanco-Vaca F
    Diabetologia; 1998 Jun; 41(6):684-93. PubMed ID: 9662051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adiponectin is inversely associated with renal function in type 1 diabetic patients.
    Schalkwijk CG; Chaturvedi N; Schram MT; Fuller JH; Stehouwer CD;
    J Clin Endocrinol Metab; 2006 Jan; 91(1):129-35. PubMed ID: 16219717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma levels of tumor necrosis factor-alpha (TNF-alpha) are essentially dependent on visceral fat amount in type 2 diabetic patients.
    Bertin E; Nguyen P; Guenounou M; Durlach V; Potron G; Leutenegger M
    Diabetes Metab; 2000 May; 26(3):178-82. PubMed ID: 10880890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum CA 19-9 Level is Correlated to the Clinical Characteristics and Chronic Complications of Patients Newly Diagnosed with Type 2 Diabetes Mellitus.
    Cui L; Lv N; Li B; Tao J; Zheng X; Yan Y; Liu C
    Exp Clin Endocrinol Diabetes; 2021 Aug; 129(8):581-586. PubMed ID: 31461764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for control of tumour necrosis factor-alpha (TNF-alpha) activity by TNF receptors in patients with proliferative diabetic retinopathy.
    Limb GA; Soomro H; Janikoun S; Hollifield RD; Shilling J
    Clin Exp Immunol; 1999 Mar; 115(3):409-14. PubMed ID: 10193411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular complications of patients in Kuwait with type 2 diabetes mellitus (NIDDM) and elevated serum lipid peroxides.
    Lanham RJ; Armstrong D; Abdella N
    Adv Exp Med Biol; 1994; 366():433-5. PubMed ID: 7771283
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.